9999999997-14-007887.txt : 20140418 9999999997-14-007887.hdr.sgml : 20140418 20140417135033 ACCESSION NUMBER: 9999999997-14-007887 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20140418 DATE AS OF CHANGE: 20140417 20140418 20140417 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Durata Therapeutics, Inc. CENTRAL INDEX KEY: 0001544116 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 871247903 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-35599 FILM NUMBER: 14769607 BUSINESS ADDRESS: STREET 1: 200 SOUTH WACKER DRIVE STREET 2: SUITE 2550 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 312-219-7000 MAIL ADDRESS: STREET 1: 200 SOUTH WACKER DRIVE STREET 2: SUITE 2550 CITY: CHICAGO STATE: IL ZIP: 60606 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C0R(#`@;V)J#3P\+TQI;F5AF4@-34O5'EP92]84F5F+U=;,2`R(#%=/CYS=')E86T-"FC>8F)D$&!@ M8F#R`A(,4X`$XPT@P1(()-AG`(E/1QF8&!EV@F09&-&)_XRS_@`$&`#5E`?D M#0IE;F1S=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@ M("`@#0HU-"`P(&]B:@T\/"]#(#8Y+T9I;'1E8F!@8&%@8(IF``*>QPRH@)$! M),O1@"S&`L4,##<8N!DXGR>P+(`JE7L,H9E2D!4;_H.(,FH!!!@`5T\'A0T* M96YD7!E+U!A9V4^/@UE;F1O8FH--#4@,"!O8FH-/#PO1FEL=&5R+T9L871E M1&5C;V1E+T9I;ORH9,4*X M(3/X].N$\T!2VA1C80V^5*DN%MY]G'O7.MFK@QN)B\IH4]KR0`Q)NF3E"OMG M;`\Y_=KV:^\/.8ZHC'Q(JF\`^E-%A&#XU/#4?7-TQ,.?0-RYSN"JAA=(P2WI M(3TNX4MWP2&K)PC$($+UG10C`AY`UG,P3B>D]YG!AIL#FTK1+WU3C6N"&IAU M]B[?Z`$Z.J0QP@GB2$3`C40(20=F',CZ$1D#QB>?+[IO*J(\IKV6GA5?:D\)ZKN>)_UES% M!OD$10$?MZ.KG*BS)3?,IJOA`;.;"KYWI^)[X.\% M?$&:^[Q8<562!C%!I>U5,:AC)$#QO1+^'A_ZI3A><4_&BJMZTXL+N47`Y?R6X7A%>"6YJS]#;B(%)8.M)&`-O.Z6W2LM]O>6O]59%1S0& M;-3_?6.$FCV.Y6/[D^/UO>P=DE0`?/N/Y?88O-P>AY/;WP(,`+D'?&0-"F5N M9'-TVD M=_D'>_WZ\G9X,V(1>_/F[6C(>I?#^X@5+S#`7HI-[W(RB9ADDX>>5"R,8!C^ MZRAE692+?LHF3SW.@LD_O:M;7-PHE%9AQ$(I9,(FHR.2RDF**-)L4L`^IO6% MA5KT^U;!HC?E'X*$C^%W$R@^N1I!B]T'H>23`30G5_?!7Y-WL"4HB7!])OHY MMA9']M9V;]I2T3K3@+UE+++4WQQV2OE5$"9\^.'N)@@UGV"'6C1,`FPP'C'J M_AG(B`]_#<*8#\:_!/5:-GR/([=!F,-'F>6TDC[4)8EQQYC#)L36A$QDB7_: M`>C>HI[G(.:K(%1\C1\F\PNF(AF3]L,Z$P<+8``(.JV'Q=,3*":BWSH5678W M(B3N&()R-P`'1GS<8$E8,1HU6(VO@[Z9,@L]V<'OA"D-W,&D3/B`.@BM%6[C MJ&(1]4]%178J*F"U;D7DV!I#VY*WC9^_,UQ,J.R'R6!(XHP00`"81/_U\:/Q M$^_;E7#(.SSZY_VC'=AK*,\IIV/V.4X-NP+Y1$J__O0 MWPE%CC`A,4B3&$*(A9IY]`EH'4]-?O9-K<-**@HK;5UOPPG9"P.IPA"982AI M#"490RS1Q-9T=G7,I:U@BJQRU)UCR-O(,NQR$TB-D07-`I<)]H)*=_,GW)Z\ M7;D/NGS!9J0X0Q1K71L8@YC>KMV:`OHX5KF1DO;8L-UF@6J>`\V9/2$0^YT) M$G-.IWC71)J*YYYX>`P]$2N[6!$NC$!:?J8.8;1\05)ID-K@X"?B6]K`(SR5 MFQ0<8:+WKD(!TB6$_@9^#Y!V5XL`CYG20+6:06O-JF>8P4'L5D]NFN&*DG@" MD_?**D&%./)$\BNKGZTJAFN_TO5'S3L8M1OB?U+X7&MX8M5C/0>\JLTR'%G- M\5.]X"UF%8HRW(A=!WFS-1"LXE'GEFDE\OC(9?[-]#/EWV`'8>B2!K!M;AU# MB*W=Z3N[A3H6TB-67FZ:VWB`AZ=81R1\1GXN'HDP)7Z[R2$1-C74V1^U"OPJ MK').<6A3#60B3\]R:'KRHFO=ONAOP4LSBLGE@DY?XI>BL@[>K64!60?OIQ5-):J20J5[O**`5Y`& M!",2>'1T4/>)%8ALW#X!#B?4B<@/13X=!-L8('TN5Q[8D4:T;^AE/3W;. MUN[P#R[5&AB9@9T5#>*-"/G"`YH&49D$-`L?!<,24U[2H9\L9:$9A2T\T113 M?)9$?6BL,1MG+`&3L/2E/6B.P^)SJ@&7]!%O7L,U>\;R`WM$X.:8K'QH*%B8 M2PKA.O4SPIEML;PN[.`%E,P?8$#<(V)B&&3@^211'SFLGW\,X$O-F)H7]3GI MB*.@UOEO$Q/.XW`,<](A1BB=9DO?O>.@I1ZD16TO,V#@F(DVPJKRO=3DN@TA M1`LL--HALRF]^"W9=C=?`W>Z?+#2',)=Y7EN%4D"IMC)[J5-&_TR*F/(O=`'0UC7#U%=2NIS;=&;SZ=HD M5:*Y[F/75M"\VV-F`,C`M3]I)]$M]$W2*V MFZB(;0RO%EU"(KIYU;$',F%\,C$U[S258Q(^EYG<^R<52OI\>17(KB_SFJ[I M3%K(EO^@)+#95$8XU^3H%@XNRQEL*>9V%,^/5K%.VXK3V*YY1YEH1Y<2*GA* MVQFM@J=,?A*8YN6F^AB*'6!:6WZ/]7'/!Q20>0!<7"KXSBDLKU% M^\),^7N?;LNY8WPM"9C0YJB;)G(D:Y]V#4%3UPA9VW_:+2*TB' M&.]4I3ZMH!#E^*L+W7;@YU@"NHIB3JXAZJLOYOG$\:-)`^\BM"Z`*'"!>0W1 M7(O\;=ZDYRE$::MDG7+BXOKQ`AK)T3,_[2SHR;0ST5`Z3JEJDG=$FXG4!OHK M`[KJG_2O\DK5?G;6O7JO5-T3V7^V[HDD>R*'2.!'.E-X81C$C(\W[!8](AC> MAH]**4!NW'ZW->&8B#QI\@$X>KWNQ)D\!V?:\$B"9-S!\_\SP(G/QP55Y/>?P(, M`'4G*0@-"F5N9'-TY!@9$1FEP'Z>@8V!F0$,$I.+"QP#`GQ`[+S\O%0&#/#M&@,C MB+ZL"S(+4QXO8$TN*"H!T@>`V"@EM3@92'\!XLSRD@*@.&,"D"V2E`UF@]2) M9(<$.0/9'4`V7TEJ!4B,P3F_H+(H,SVC1,'0TM)2P3$E/RE5(;BRN"0UMUC! M,R\YOZ@@ORBQ)#4%J!9J!PCPNQ`P M8A0[CQ!#@.32HC(HDY')F($!(,``2<8X+PT*96YDW)+!;MLP#(9?A6\@ MBY1L&2@"=-T*#,6R(,E.10]>*J3&6MMP':!]^_TVLVX[C+WODA\2F4_T)Y54 M4$5)*)$4B6H2KL@7%%G(>ZKF%5,5$4)50@1*'A$I!41)J4)45!<(``114UU6 MQ`75-<*#!PPS,B::P46JB0,.0`]'9/3$)3(Q+2?B,$[($(AK9!4Q'D8H2A+P M!*<(>%)B;/"DQN#@!30)>*'T)."%FFD>:/X:`2_&0`)>3)$N+MP-/KV@K=LT M8^ZF_9@S-/R]L^V_6/^T@Q0-'?L7X?L=M-X.BQMV[Z?5JL9>0MK M:)BM+2$:02-JE!J51M)8P+.U)93"2F&EL%)8*:P45@HKA94B2A&EB%)$*:(4 M48HH190B2I&%>N M'IIQ4]/@?SV1^Y/TWEY^OY\&-OA;3GD\<^-/2[R0__B+C':M^X^CV^D MU>I_NK/E61>XN?/3/E((YSO$>6 M;FMC.60B M/SX*/'@Z>&UP;65T82!X;6QN#IX;7!T M:STB061O8F4@6$U0($-O&UP.DUE=&%D871A1&%T93X*("`@("`@("`@/'AM<#I# M&UP34TZ&UP34TZ&UL M.FQA;F<](G@M9&5F875L="(O/@H@("`@("`@("`@("`\+W)D9CI!;'0^"B`@ M("`@("`@(#PO9&,Z=&ET;&4^"B`@("`@("`@(#QD8SIC&UL;G,Z<&1F>#TB M:'1T<#HO+VYS+F%D;V)E+F-O;2]P9&9X+S$N,R\B/@H@("`@("`@("`\<&1F M>#I3;W5R8V5-;V1I9FEE9#Y$.C(P,30P-#$W,3#I#;VUP86YY/E-E8W5R:71I97,@ M86YD($5X:&%N9V4@0V]M;6ES#I#;VUP86YY/@H@("`@("`@ M("`\<&1F>#I#;VUM96YT#I#;VUM96YT7!E+T]B M:E-T;3X^D[+U2^>2B8:I-A&VUVI@+,BC95]`2PY'8%N6&['_0\`UMF6QJ,$N6:NP< M6+N:#=\[*K^^H\0-9L>U#NU?:**GHW%1[EW\05',YP\!!@#+Q%&/#0IE;F1S M=')E86T-96YD;V)J#34@,"!O8FH-/#PO1&5C;V1E4&%R;7,\/"]#;VQU;6YS M(#0O4')E9&EC=&]R(#$R/CXO1FEL=&5R+T9L871E1&5C;V1E+TE$6SQ%0D(Q M,$0V-#8U,S8P,S0R0D$X-D5!,#$Q-4,Q.3